Gorinchem, Netherlands

Jenny Eelderink

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 1 EPO patent. Top assignee: Purac Biochem Bv. Active years: 2024.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jenny Eelderink: Innovator in Antibacterial Agents

Introduction

Jenny Eelderink is a notable inventor based in Gorinchem, Netherlands. She has made significant contributions to the field of biochemistry, particularly in the development of antibacterial agents. Her innovative work focuses on enhancing fermentation processes by suppressing the growth of contaminating bacteria.

Latest Patents

Jenny Eelderink holds a patent for "Fatty acid esters against infections in fermentations." This invention presents an antibacterial agent that effectively suppresses the growth of gram-positive contaminating bacteria. The antibacterial agent is selected from a lactylate and a glycerol ester, with specific general formulae that define the acyl groups and counter-cations involved. This patent represents her commitment to advancing biochemistry and improving fermentation processes.

Career Highlights

Eelderink is currently associated with Purac Biochem Bv, where she continues to innovate in the field of biochemistry. Her work has been instrumental in developing solutions that address challenges in fermentation and bacterial contamination.

Collaborations

Throughout her career, Jenny has collaborated with talented individuals such as Roel Otto and Aldana Mariel Ramirez. These collaborations have further enriched her research and contributed to her success in the field.

Conclusion

Jenny Eelderink is a pioneering inventor whose work in antibacterial agents has the potential to significantly impact fermentation processes. Her dedication to innovation and collaboration highlights her important role in the field of biochemistry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…